急性脑梗塞非溶栓治疗临床过程及超早期治疗可行性研究

用NationalInstituesofHealthStrokeScale表对接受非溶栓治疗的56倒24h内就诊的脑梗塞患者进行临床分析，结果显示平均20d后症状才开始改善并随时间延长症状进一步改善，但48h到7d这一阶段症状有一过性加重。6h内治疗者症状改善早于6～24h治疗者，且临床预后好，表明应早期治疗。病后6h内就诊者占5％，3d内就诊者约50％。提示加强宣传力度，普及卒中常识，建立卒中急救系统可能使更多的患者接受超早期治疗。

Applicable Study of Super Early Nonthrombolytic Treatment for Acute Cerebral Infarction and Its Clinical Implication

Using National Institues of Health Stroke Scale, we investigated 56 patients with acute cerebral infarction admitted within 24 hours after onset who received nonthrombolytic therapy. The results indicated that the patient's symptoms began to improve after 20 days of treatment, but aggravated transiently during 48 hours to 7 days after treatment. The patients received treatment within 6 hours gain better results than 6~24 hours. The patients with larger infarction area had worse results than smaller. We therefore suggest that super early treatment may improve the clinical outcome.